MedPath

Effect of Pneumoperitoneum on Remifentanil Requirements in the Surgical Pleth Index-guided Analgesia

Not Applicable
Completed
Conditions
Gastric Cancer
Registration Number
NCT03788447
Lead Sponsor
Ajou University School of Medicine
Brief Summary

The primary purpose of this study is to investigate the effect of pneumoperitoneum on remifentanil requirements in the surgical pleth index-guided analgesia for laparoscopic gastrectomy.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
74
Inclusion Criteria
  • laparoscopic gastrectomy under general anesthesia
Exclusion Criteria
  • atypical hemoglobin disease, infective state, cardiovascular disease, peripheral vascular disease

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
total dose of remifentanilthrough study completion, an average of 2 hours

total dose of remifentanil to maintain for surgical pleth index \< 50

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Department of Anesthesiology and Pain Medicine, Ajou University School of Medicine

🇰🇷

Suwon, Seoul, Korea, Republic of

Department of Anesthesiology and Pain Medicine, Ajou University School of Medicine
🇰🇷Suwon, Seoul, Korea, Republic of

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.